摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Tert-butyl(4-chloro-2-iodophenoxy)dimethylsilane | 1235406-55-9

中文名称
——
中文别名
——
英文名称
Tert-butyl(4-chloro-2-iodophenoxy)dimethylsilane
英文别名
tert-butyl-(4-chloro-2-iodophenoxy)-dimethylsilane
Tert-butyl(4-chloro-2-iodophenoxy)dimethylsilane化学式
CAS
1235406-55-9
化学式
C12H18ClIOSi
mdl
——
分子量
368.717
InChiKey
HAHSSNYPANFBKS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    290.3±25.0 °C(Predicted)
  • 密度:
    1.387±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    5.33
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    参考文献:
    名称:
    One-pot synthesis of 2,2′-bisbenzofurans using cuprous chloride as a catalyst
    摘要:
    A variety of novel 5,5'-disubstituted-2,2'-bisbenzofuran derivatives were synthesized by treatment of 4-substituted-2-(2-trimethylsilylethynyl)phenyl tert-butyldimethylsilyl ether analogues with Cud I as a catalyst in 62-82% isolated yields. This novel strategy provides a straightforward and simple pathway for the preparation of 2,2'-bisbenzofuran derivatives of interest in life and material sciences. (c) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2013.03.040
  • 作为产物:
    描述:
    参考文献:
    名称:
    One-pot synthesis of 2,2′-bisbenzofurans using cuprous chloride as a catalyst
    摘要:
    A variety of novel 5,5'-disubstituted-2,2'-bisbenzofuran derivatives were synthesized by treatment of 4-substituted-2-(2-trimethylsilylethynyl)phenyl tert-butyldimethylsilyl ether analogues with Cud I as a catalyst in 62-82% isolated yields. This novel strategy provides a straightforward and simple pathway for the preparation of 2,2'-bisbenzofuran derivatives of interest in life and material sciences. (c) 2013 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2013.03.040
点击查看最新优质反应信息

文献信息

  • Convenient and Highly Efficient Routes to 2  <i>H</i> ‐Chromene and 4‐Chromanone Derivatives: Iodine‐Promoted and <i>p</i> ‐Toluenesulfonic Acid Catalyzed Cascade Cyclizations of Propynols
    作者:Yi‐Feng Qiu、Yu‐Ying Ye、Xian‐Rong Song、Xin‐Yu Zhu、Fang Yang、Bo Song、Jia Wang、Hui‐Liang Hua、Yu‐Tao He、Ya‐Ping Han、Xue‐Yuan Liu、Yong‐Min Liang
    DOI:10.1002/chem.201406100
    日期:2015.2.16
    A convenient strategy is presented for the easy preparation of a series of 2Hchromenes under mild conditions through iodocyclization of readily accessible propynols. In addition, various 4chromanones can be synthesized through a ptoluenesulfonic acid catalyzed cascade cyclization with high efficiency (yields up to 99 %). Our developed reaction systems are proven to have good functional‐group applicability
    提出了一种简便的策略,可以通过容易获得的丙炔醇的环化,在温和条件下轻松制备一系列2  H-色烯。此外,可以通过p合成各种4-chromanones甲苯磺酸高效催化级联环化(产率高达99%)。我们开发的反应系统经验证具有良好的官能团适用性,并且可以按比例放大至克数量,并具有令人满意的产率。这些系统还为两种重要的类黄酮骨架提供了新的合成策略,而无需使用昂贵且有毒的属催化剂。此外,生成的卤化物可进一步用于随后的催化的偶联反应中,因此这些化合物可作为潜在的中间体,用于构建某些有价值的药物分子。
  • SULFONAMIDE DERIVATIVES
    申请人:Beaudoin Serge
    公开号:US20100197655A1
    公开(公告)日:2010-08-05
    The present invention relates to compounds of the formula and pharmaceutically acceptable salts, solvates or tautomers thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds, and the uses of such compounds, in particular for the treatment of pain.
    本发明涉及以下公式的化合物及其药学上可接受的盐、溶剂物或互变异构体,制备这些化合物的过程中使用的中间体,以及含有这些化合物的组合物,以及这些化合物的用途,特别是用于治疗疼痛。
  • Sulfonamide derivatives
    申请人:Pfizer Limited
    公开号:US08153814B2
    公开(公告)日:2012-04-10
    The present invention relates to compounds of the formula and pharmaceutically acceptable salts, solvates or tautomers thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds, and the uses of such compounds, in particular for the treatment of pain.
    本发明涉及公式化合物及其药学上可接受的盐、溶剂化合物或互变异构体,制备这些化合物的方法、用于制备中间体的中间体、含有这些化合物的组合物,以及这些化合物的用途,特别是用于治疗疼痛。
  • Sulfonamide Derivatives
    申请人:Beaudoin Serge
    公开号:US20120149679A1
    公开(公告)日:2012-06-14
    The present invention relates to compounds of the formula and pharmaceutically acceptable salts, solvates or tautomers thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds, and the uses of such compounds, in particular for the treatment of pain.
    本发明涉及以下公式的化合物及其药学上可接受的盐、溶剂合物或互变异构体,制备这些化合物的过程中使用的中间体,含有这些化合物的组合物,以及这些化合物的用途,特别是用于治疗疼痛。
  • BF<sub>3</sub>·Et<sub>2</sub>O-Promoted Cleavage of the C<sub>sp</sub>–C<sub>sp2</sub> Bond of 2-Propynolphenols/Anilines: Route to C2-Alkenylated Benzoxazoles and Benzimidazoles
    作者:Xian-Rong Song、Yi-Feng Qiu、Bo Song、Xin-Hua Hao、Ya-Ping Han、Pin Gao、Xue-Yuan Liu、Yong-Min Liang
    DOI:10.1021/jo502761x
    日期:2015.2.20
    A novel BF3 center dot Et2O-promoted tandem reaction of easily prepared 2-propynolphenols/anilines and trimethylsilyl azide is developed to give C2-alkenylated benzoxazoles and benzimidazoles in moderate to good yields. Most reactions could be accomplished in 30 min at room temperature. This tandem process involves a C-sp-C-sp2 bond cleavage and a C-N bond formation. Moreover, both tertiary and secondary propargylic alcohols with diverse functional groups were tolerated under the mild conditions.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫